This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WebMD Study: U.S. Doctors Deeply Divided On Many Matters Of Ethical Ambiguity

The Medscape 2012 Ethics Survey found that 12% of physicians said "yes" and 13% said "it depends" when asked if it is acceptable to overstate or falsify a patient's condition when submitting claims or seeking prior authorization. The majority (75%) of responding physicians, however, said "no."

To learn more about the Medscape 2012 Ethics Survey findings and qualitative physician responses, visit http://www.medscape.com/features/slideshow/public/ethics2012.

For additional information on ethics within the business of medicine, visit http://www.medscape.com/resource/ethics.

*Medscape 2012 Ethics Survey Methodology: Medscape's 2012 Ethics Survey was intended to identify how U.S. physicians would react to a wide range of ethical dilemmas and which ethical dilemmas are the most difficult to navigate. Medscape conducted the survey during August and September and received responses from more than 24,000 physicians across 25 specialties.

About Medscape

Medscape is the flagship site in WebMD's Professional Network. Medscape and Medscape Mobile are free, registration-based services that provide physicians and other health care professionals with comprehensive resources across 30 medical specialty areas, including medical news and perspectives, clinical reference tools, and continuing medical education.  

About WebMD

WebMD Health Corp. (NASDAQ: WBMD) is the leading provider of health information services, serving consumers, physicians, health care professionals, employers, and health plans through our public and private online portals, mobile platforms, and health-focused publications.

The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, eMedicineHealth, RxList, theheart.org, Medscape Education, and other owned WebMD sites.

SOURCE WebMD Health Corp.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs